Gentex Corporation GNTX
22.58
0.54
2.45%
as of 25 Sep
- Market cap
- $4.6B
- P/E
- 11.9×
Follow GNTX
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.37 | 12.28 | 13.37 | 16.65 |
+8 more quarters Free account |
P/S ratio |
2.01 | 1.75 | 2.00 | 2.51 | |
P/FCF ratio |
10.43 | 9.73 | 10.87 | 12.88 | |
P/Operating CF |
28.56 | 33.70 | 40.39 | 41.58 | |
P/B ratio |
2.08 | 1.85 | 2.04 | 2.45 | |
Price to Tangible BV |
2.77 | 2.46 | 2.73 | 3.28 | |
EV/Sales |
1.92 | 1.69 | 1.94 | 2.44 | |
EV/EBITDA |
8.21 | 7.56 | 8.52 | 10.69 | |
EV/Operating CF |
8.47 | 7.73 | 8.38 | 9.63 | |
EV/FCF |
9.96 | 9.37 | 10.55 | 12.51 | |
Quick Ratio |
1.55 | 1.34 | 1.34 | 1.44 | |
Current Ratio |
3.04 | 2.72 | 2.91 | 2.96 | |
Net Debt/EBITDA |
(1.43) | (1.17) | (1.04) | (1.24) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.90 | 0.91 | 0.89 | 0.86 | |
Operating CF/Net income |
1.64 | 1.41 | 1.37 | 1.48 | |
Capex/Depreciation |
(0.66) | (0.66) | (0.69) | (1.37) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.56% | 7.65% | 8.26% | 8.03% | |
Selling, General and Administrative Expense of Revenue |
7.68% | 7.37% | 7.72% | 7.58% | |
Intangible Assets out of Total Assets |
0.21 | 0.21 | 0.21 | 0.21 | |
Share Based Compensation of Revenue |
1.49% | 1.54% | 1.56% | 1.59% | |
Graham Net Nets |
0.15 | 0.15 | 0.14 | 0.12 | |
Graham Number |
22.75 | 21.77 | 21.15 | 21.02 | |
Earnings Yield |
7.48% | 8.15% | 7.48% | 6.01% | |
Free Cash Flow Yield |
9.59% | 10.27% | 9.20% | 7.76% | |
Revenue per Share |
3.12 | 3.19 | 2.96 | 3.03 | |
Operating CF per Share |
0.88 | 0.65 | 0.58 | 0.68 | |
Capex per Share |
(0.09) | (0.08) | (0.08) | (0.16) | |
Free Cash Flow per Share |
0.79 | 0.57 | 0.50 | 0.52 | |
Cash per Share |
1.16 | 0.83 | 0.69 | 0.85 | |
Shareholders Equity per Share |
12.17 | 11.84 | 11.42 | 11.55 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.17 | 11.84 | 11.42 | 11.55 | |
Free Cash Flow |
165.76 | 120.11 | 107.98 | 111.41 | |
Working Capital |
825.81 | 763.61 | 740.89 | 774.02 | |
Capital Expenditures |
(18.82) | (16.97) | (17.52) | (35.57) | |
Net Current Asset Value |
769.60 | 713.14 | 687.67 | 724.93 | |
EV/EBIT |
9.92 | 9.18 | 10.39 | 13.37 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.05 | |
Net Profit Margin |
17.32% | 14.35% | 14.20% | 15.18% | |
Price to Operating Income |
10.39 | 9.53 | 10.70 | 13.78 | |
| Other line items | |||||
Average Receivables |
379.65 | 375.05 | 331.93 | 370.51 | |
Average Payables |
226.47 | 219.77 | 208.65 | 217.32 | |
Average Inventory |
497.34 | 466.22 | 476.38 | 474.28 | |
Average Assets |
2,906.62 | 2,890.09 | 2,844.71 | 2,837.03 | |
Average Common Equity |
2,484.37 | 2,491.00 | 2,479.97 | 2,456.42 |
Columns are period end dates